Yuhua Li Selected Research

4-(5-naphthyl-3- (trifluoromethyl)- 1H- pyrazol- 1- yl)benzenesulfonamide

12/2009

PC-407, a celecoxib derivative, inhibited the growth of colorectal tumor in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuhua Li Research Topics

Disease

55	Neoplasms (Cancer) 04/2022 - 06/2008
13	Leukemia 01/2022 - 03/2000
12	Carcinogenesis 01/2022 - 12/2009
12	Colorectal Neoplasms (Colorectal Cancer) 07/2019 - 12/2009
11	Inflammation (Inflammations) 01/2022 - 12/2009
9	Infections 12/2022 - 04/2002
9	Colitis-Associated Neoplasms 04/2022 - 12/2009
9	Colitis 04/2021 - 12/2009
8	Breast Neoplasms (Breast Cancer) 09/2021 - 03/2010
8	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 02/2009
6	Japanese Encephalitis 06/2022 - 10/2014
6	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2015
6	Hematologic Neoplasms (Hematological Malignancy) 11/2021 - 08/2015
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 10/2017
5	COVID-19 12/2022 - 01/2020
5	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 03/2000
5	Hepatocellular Carcinoma (Hepatoma) 08/2019 - 12/2010
5	Carcinoma (Carcinomatosis) 01/2019 - 06/2008
4	Rabies (Hydrophobia) 07/2022 - 01/2019
4	Colonic Neoplasms (Colon Cancer) 04/2022 - 02/2012
4	Acute Lung Injury 02/2022 - 04/2009
4	Dysbiosis 12/2020 - 02/2020
4	Atherosclerosis 01/2008 - 04/2005
3	Osteolysis 01/2022 - 10/2019
3	Lymphoma (Lymphomas) 01/2022 - 01/2019
3	Lung Injury 01/2021 - 04/2009
3	Toxoplasmosis 04/2020 - 01/2018
3	Lung Neoplasms (Lung Cancer) 09/2015 - 01/2013
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2022 - 01/2019
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 01/2020
2	Dengue (Dengue Fever) 01/2022 - 10/2014
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2019
2	Hypersensitivity (Allergy) 09/2021 - 03/2017
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 04/2021 - 12/2009
2	Thrombocytopenia (Thrombopenia) 01/2021 - 11/2017
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020 - 10/2017
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2007
21	VaccinesIBA 12/2022 - 04/2002
11	Chimeric Antigen ReceptorsIBA 11/2021 - 01/2019
11	Polysaccharides (Glycans)IBA 10/2020 - 12/2009
11	ErbB Receptors (EGF Receptor)IBA 05/2019 - 08/2013
9	AntigensIBA 01/2022 - 12/2010
7	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2012
7	Pharmaceutical PreparationsIBA 01/2021 - 01/2011
6	EnzymesIBA 01/2022 - 03/2011
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 10/2014
6	Peptides (Polypeptides)IBA 12/2019 - 02/2015
5	LipidsIBA 05/2022 - 03/2006
5	Chloride Channels (Chloride Channel)IBA 04/2022 - 12/2009
5	ApolipoproteinsIBA 01/2008 - 04/2005
4	Attenuated VaccinesIBA 06/2022 - 01/2017
4	Messenger RNA (mRNA)IBA 02/2022 - 02/2009
4	Amino Acids FDA Link 01/2022 - 01/2018
4	MicroRNAs (MicroRNA)IBA 12/2021 - 03/2010
4	Sulfonic AcidsIBA 04/2021 - 12/2009
4	CytokinesIBA 01/2021 - 12/2009
4	AndrogensIBA 01/2020 - 02/2009
4	Paris saponin VIIIBA 07/2019 - 03/2014
4	Dextrans (Dextran)FDA Link 10/2017 - 03/2014
4	LigandsIBA 05/2012 - 02/2009
3	cortistatinIBA 01/2022 - 03/2019
3	TitaniumIBA 01/2022 - 10/2019
3	sym-trinitrobenzeneIBA 04/2021 - 12/2009
3	Glycoproteins (Glycoprotein)IBA 02/2021 - 01/2018
3	Phosphotransferases (Kinase)IBA 04/2020 - 01/2016
3	GhrelinIBA 01/2020 - 01/2019
3	EpitopesIBA 12/2019 - 02/2015
3	SaponinsIBA 07/2019 - 07/2014
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 10/2014
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2017 - 03/2014
3	Dimenhydrinate (DMH)FDA LinkGeneric 06/2015 - 02/2012
3	LipopolysaccharidesIBA 10/2013 - 01/2011
3	CholesterolIBA 01/2008 - 03/2006
3	Apolipoproteins E (ApoE)IBA 05/2006 - 04/2005
2	ParaquatIBA 02/2022 - 10/2020
2	mRNA VaccinesIBA 01/2022 - 01/2021
2	Basiliximab FDA Link 01/2022 - 07/2015
2	Guanosine Triphosphate (GTP)IBA 01/2022 - 10/2014
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2014
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 03/2014
2	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2021 - 01/2011
2	Chemokine CXCL1IBA 12/2020 - 02/2009
2	AntibodiesIBA 10/2020 - 01/2018
2	Inosine Triphosphate (ITP)IBA 01/2020 - 10/2017
2	AntioxidantsIBA 01/2020 - 01/2018
2	CateninsIBA 01/2020 - 10/2019
2	C-Reactive ProteinIBA 01/2020 - 10/2014
2	Amyloid (Amyloid Fibrils)IBA 01/2020 - 05/2006
2	Cancer VaccinesIBA 01/2020 - 08/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2019 - 07/2014
2	A-Form DNA (A-DNA)IBA 01/2019 - 01/2018
2	Oncogene Proteins (Oncogene Protein)IBA 01/2019 - 01/2016

Therapy/Procedure

27	Therapeutics 01/2022 - 05/2011
14	Immunotherapy 01/2022 - 12/2010
11	Drug Therapy (Chemotherapy) 04/2022 - 03/2010
5	Hematopoietic Stem Cell Transplantation 01/2021 - 07/2015
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2015 - 12/2009
2	Immunomodulation 01/2022 - 12/2009
2	Transplantation 01/2020 - 03/2000